Structural and functional studies of Wnt signalling pathway antagonists

<p>Wnt morphogens control embryonic development and adult tissue homeostasis. Deregulation of the Wnt signalling pathway leads to human diseases. This thesis covers work on two antagonists of the Wnt signalling pathway, Wnt inhibitory factor 1 (WIF-1) (Chapters 1 to 5) and secreted Frizzled-re...

Full description

Bibliographic Details
Main Author: Malinauskas, T
Other Authors: Jones, E
Format: Thesis
Language:English
Published: 2011
Subjects:
_version_ 1826288880132816896
author Malinauskas, T
author2 Jones, E
author_facet Jones, E
Malinauskas, T
author_sort Malinauskas, T
collection OXFORD
description <p>Wnt morphogens control embryonic development and adult tissue homeostasis. Deregulation of the Wnt signalling pathway leads to human diseases. This thesis covers work on two antagonists of the Wnt signalling pathway, Wnt inhibitory factor 1 (WIF-1) (Chapters 1 to 5) and secreted Frizzled-related protein 1 (sFRP-1) (Chapters 1 and 6). In vertebrates the N-terminal WIF domain of the six-domain WIF-1 and the cysteine-rich domain of the two-domain sFRP-1 bind to Wnt proteins and inhibit signal transduction.</p><p>My human WIF domain crystal structure reveals a novel binding site for phospholipid. Two acyl chains of the phospholipid extend deep into the domain while the lipid head group is surface exposed. Biophysical and cellular assays, combined with structure-guided mutagenesis, indicate a WIF domain Wnt-binding surface proximal to the lipid head group, but also implicate the five epidermal growth factor (EGF)-like domains (EGFs I–V) in Wnt binding. The crystal structure of the six-domain WIF-1 reveals EGFs I–V wrapped-back to interface with the WIF domain at EGF III. Binding studies locate a heparan sulfate proteoglycan-binding site in EGFs II–V, consistent with highly conserved, positively charged residues on EGF IV.</p><p>My human sFRP-1 cysteine-rich domain crystal structures reveal a conserved hydrophobic homodimer interface, conformationally variant N- and C-termini, and a conformationally invariant, putative Wnt-binding site. The site is located proximal to a positively charged surface region, which is consistent with the observed sFRP-1 cysteine-rich domain binding to heparin and heparan sulfate.</p><p>The combination of heparan sulfate proteoglycan- and Wnt-binding properties suggests a model for WIF-1 and sFRP-1 localisation, and signalling inhibition, within Wnt morphogen gradients. The findings described in this thesis provide insights into the medically-important mechanisms of Wnt signalling pathway.</p>
first_indexed 2024-03-07T02:20:24Z
format Thesis
id oxford-uuid:a3b71f18-9b90-408a-a5b5-2611e4ae2102
institution University of Oxford
language English
last_indexed 2024-03-07T02:20:24Z
publishDate 2011
record_format dspace
spelling oxford-uuid:a3b71f18-9b90-408a-a5b5-2611e4ae21022022-03-27T02:28:58ZStructural and functional studies of Wnt signalling pathway antagonistsThesishttp://purl.org/coar/resource_type/c_db06uuid:a3b71f18-9b90-408a-a5b5-2611e4ae2102Biology (medical sciences)BiologyMolecular biophysics (biochemistry)BiochemistryOncologyEnglish2011Malinauskas, TJones, E<p>Wnt morphogens control embryonic development and adult tissue homeostasis. Deregulation of the Wnt signalling pathway leads to human diseases. This thesis covers work on two antagonists of the Wnt signalling pathway, Wnt inhibitory factor 1 (WIF-1) (Chapters 1 to 5) and secreted Frizzled-related protein 1 (sFRP-1) (Chapters 1 and 6). In vertebrates the N-terminal WIF domain of the six-domain WIF-1 and the cysteine-rich domain of the two-domain sFRP-1 bind to Wnt proteins and inhibit signal transduction.</p><p>My human WIF domain crystal structure reveals a novel binding site for phospholipid. Two acyl chains of the phospholipid extend deep into the domain while the lipid head group is surface exposed. Biophysical and cellular assays, combined with structure-guided mutagenesis, indicate a WIF domain Wnt-binding surface proximal to the lipid head group, but also implicate the five epidermal growth factor (EGF)-like domains (EGFs I–V) in Wnt binding. The crystal structure of the six-domain WIF-1 reveals EGFs I–V wrapped-back to interface with the WIF domain at EGF III. Binding studies locate a heparan sulfate proteoglycan-binding site in EGFs II–V, consistent with highly conserved, positively charged residues on EGF IV.</p><p>My human sFRP-1 cysteine-rich domain crystal structures reveal a conserved hydrophobic homodimer interface, conformationally variant N- and C-termini, and a conformationally invariant, putative Wnt-binding site. The site is located proximal to a positively charged surface region, which is consistent with the observed sFRP-1 cysteine-rich domain binding to heparin and heparan sulfate.</p><p>The combination of heparan sulfate proteoglycan- and Wnt-binding properties suggests a model for WIF-1 and sFRP-1 localisation, and signalling inhibition, within Wnt morphogen gradients. The findings described in this thesis provide insights into the medically-important mechanisms of Wnt signalling pathway.</p>
spellingShingle Biology (medical sciences)
Biology
Molecular biophysics (biochemistry)
Biochemistry
Oncology
Malinauskas, T
Structural and functional studies of Wnt signalling pathway antagonists
title Structural and functional studies of Wnt signalling pathway antagonists
title_full Structural and functional studies of Wnt signalling pathway antagonists
title_fullStr Structural and functional studies of Wnt signalling pathway antagonists
title_full_unstemmed Structural and functional studies of Wnt signalling pathway antagonists
title_short Structural and functional studies of Wnt signalling pathway antagonists
title_sort structural and functional studies of wnt signalling pathway antagonists
topic Biology (medical sciences)
Biology
Molecular biophysics (biochemistry)
Biochemistry
Oncology
work_keys_str_mv AT malinauskast structuralandfunctionalstudiesofwntsignallingpathwayantagonists